Literature DB >> 24521018

A 'bird's eye' view on the current status and potential benefits of blood biomarkers for Parkinson's disease.

Michelle M Mielke1, Walter Maetzler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24521018     DOI： 10.2217/bmm.13.139

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  7 in total

Review 1.  Biomarkers of Parkinson's disease: present and future.

Authors:  Diane B Miller; James P O'Callaghan
Journal:  Metabolism       Date:  2014-10-31       Impact factor: 8.694

2.  Instrumented functional reach test differentiates individuals at high risk for Parkinson's disease from controls.

Authors:  Sandra E Hasmann; Daniela Berg; Markus A Hobert; David Weiss; Ulrich Lindemann; Johannes Streffer; Inga Liepelt-Scarfone; Walter Maetzler
Journal:  Front Aging Neurosci       Date:  2014-10-24       Impact factor: 5.750

3.  Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.

Authors:  Felix P Bernhard; Sebastian Heinzel; Gerhard Binder; Karin Weber; Anja Apel; Benjamin Roeben; Christian Deuschle; Mirjam Maechtel; Tanja Heger; Susanne Nussbaum; Thomas Gasser; Walter Maetzler; Daniela Berg
Journal:  PLoS One       Date:  2016-03-11       Impact factor: 3.240

4.  Commentary: Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.

Authors:  Yassar Alamri; Michael MacAskill; Tim Anderson
Journal:  Front Aging Neurosci       Date:  2017-01-09       Impact factor: 5.750

Review 5.  Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review.

Authors:  Arun T Nair; Vadivelan Ramachandran; Nanjan M Joghee; Shanish Antony; Gopalakrishnan Ramalingam
Journal:  J Neurogastroenterol Motil       Date:  2018-01-30       Impact factor: 4.924

6.  Analysis of repetitive element expression in the blood and skin of patients with Parkinson's disease identifies differential expression of satellite elements.

Authors:  Kimberley J Billingsley; Freddy Lättekivi; Anu Planken; Ene Reimann; Lille Kurvits; Liis Kadastik-Eerme; Kristjan M Kasterpalu; Vivien J Bubb; John P Quinn; Sulev Kõks; Pille Taba
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

7.  GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia.

Authors:  Walter Maetzler; Willy Deleersnijder; Valérie Hanssens; Alice Bernard; Kathrin Brockmann; Justus Marquetand; Isabel Wurster; Tim W Rattay; Lorenzo Roncoroni; Eva Schaeffer; Stefanie Lerche; Anja Apel; Christian Deuschle; Daniela Berg
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.